Safety of oral ibandronate in the treatment of bone metastases from breast cancer : long-term follow-up experience

Clin Drug Investig. 2006;26(1):43-8. doi: 10.2165/00044011-200626010-00006.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary*
  • Breast Neoplasms / pathology*
  • Creatinine / blood
  • Diphosphonates / adverse effects*
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Humans
  • Ibandronic Acid
  • Kidney / drug effects
  • Middle Aged

Substances

  • Diphosphonates
  • Creatinine
  • Ibandronic Acid